Contact this trialFirst, we need to learn more about you.
VEGF Inhibitor
High-Dose Aflibercept for Macular Edema
Recruiting2 awardsPhase 3
Hauppauge, New York
This trial is researching a higher dose of intravitreal aflibercept for patients with macular edema due to retinal vein occlusion, which could reduce the number of injections needed.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.